ResMed reports stellar result
06 August, 2008 by Dylan Bushell-EmblingResMed's share price soars following impressive fourth-quarter and financial year earnings figures.
HeartWare to go OS
05 August, 2008 by Dylan Bushell-EmblingHeartWare to transfer corporate responsibility to US
Streamline for QRxPharma
05 August, 2008 by Dylan Bushell-EmblingFDA approves QRxPharma's streamlined testing protocol
Minomic says no to Probiomics
31 July, 2008 by Kate McDonaldMinomic has withdrawn from a proposed merger with Probiomics
Hexima puts up its defensins
31 July, 2008 by Dylan Bushell-EmblingHexima releases details of field trials against common crop fungal pathogens
Portland denies patent infringement
31 July, 2008 by Dylan Bushell-EmblingSydney prosthetics companies in hip cup barney
OMI heads north again
31 July, 2008 by Dylan Bushell-EmblingOMI finds Canadian distribution partner for safety syringes
Biota completes new flu trial
31 July, 2008 by Dylan Bushell-EmblingPhase II trials of long-acting compound conclude, Phase III next
Innovation review extended
31 July, 2008 by Kate McDonaldDeadline for Innovation Review green paper extended by a month
ASCC board sacks Livesey
31 July, 2008 by Kate McDonaldStephen Livesey has "departed" the ASCC over difference with board
AtCor's pressure rises
30 July, 2008 by Dylan Bushell-EmblingExcellent sales results reported by AtCor
Lancet for Prana
30 July, 2008 by Dylan Bushell-EmblingLancet Neurology publishes Prana's PBT2 trial results
Oncaidia's best practice
30 July, 2008 by Dylan Bushell-EmblingOncaidia wins award Frost & Sullivan award for Apomab technology
Mayo specialist for Cytopia
30 July, 2008 by Dylan Bushell-EmblingCytopia appoints clinical trial chair
Pond scum and the biofuel revolution
29 July, 2008 by Staff WritersMurdoch Uni wins grant to research turning algae into energy
